New England Securities’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
$19K Sell
75
-1,130
-94% -$282K 0.01% 914
2014
Q3
$291K Buy
1,205
+345
+40% +$77.2K 0.1% 211
2014
Q2
$192K Sell
860
-14
-2% -$2.9K 0.07% 316
2014
Q1
$180K Sell
874
-459
-34% -$90.9K 0.07% 277
2013
Q4
$224K Sell
1,333
-125
-9% -$19.5K 0.09% 238
2013
Q3
$210K Buy
1,458
+313
+27% +$41.7K 0.11% 217
2013
Q2
$145K Buy
+1,145
New +$130K 0.1% 226

Other funds holding AGN

New England Securities's AGN Position: Q4 2014 in Review

New England Securities reduced its Allergan plc (AGN) stake by 94% in Q4 2014, selling an estimated $282K and leaving 75 shares worth $19K. The position accounts for 0.01% of the portfolio, ranked #914.

New England Securities first reported a position in AGN in Q2 2013 and has held it in 7 quarters since. The position peaked at $291K in Q3 2014. 840 funds tracked by Wall St. Rank hold AGN as of Q4 2014.

  • New England Securities held 75 shares of Allergan plc worth $19K as of Q4 2014.
  • New England Securities sold 1,130 Allergan plc shares in Q4 2014, an estimated $282K.
  • Allergan plc made up 0.01% of New England Securities's portfolio in Q4 2014, its #914 holding.
  • New England Securities first reported a position in Allergan plc in Q2 2013 and has held it in 7 quarters since.
  • New England Securities's Allergan plc position peaked at $291K in Q3 2014.
  • 840 funds tracked by Wall St. Rank held Allergan plc as of Q4 2014.

Based on New England Securities's 13F filing for Q4 2014, filed 26 Jan 2015.